PHVS insiders report Rule 144 / 10b5-1 sales

PHVS-related holders reported planned dispositions of Common stock under Rule 144/10b5-1.

Rhea-AI Filing Summary

PHVS-related holders reported planned dispositions of Common stock under Rule 144/10b5-1. The filing lists multiple 10b5-1 sales by Anne Simonne J. Lesage and Graymatters Consulting on 04/30/2026 and 06/25/2026, with per-trade share counts and proceeds shown in the filing.

Insights

Corporate Governance Analyst

Multiple scheduled 10b5-1 dispositions by named holders are recorded; these are mechanistic insider sales.

Forms show routine, pre-arranged sales under 10b5-1 for Anne Simonne J. Lesage and Graymatters Consulting, with discrete trade dates and proceeds. The filing lists exact share counts and dollar proceeds per trade.

These transactions are execution of arranged plans; cash-flow treatment and broader ownership impact are not described in the excerpt. Subsequent filings may disclose additional trades or position changes.

Key Figures

Sale on 04/30/2026 (Lesage): 21,700 shares Proceeds on 04/30/2026 (Lesage): $656,550.86 Sale on 04/30/2026 (Graymatters): 19,200 shares +3 more

6 metrics

Sale on 04/30/2026 (Lesage) 21,700 shares 10b5-1 sale by Anne Simonne J. Lesage on <date>04/30/2026</date>

Proceeds on 04/30/2026 (Lesage) $656,550.86 Dollar proceeds for the 21,700-share sale on <date>04/30/2026</date>

Sale on 04/30/2026 (Graymatters) 19,200 shares 10b5-1 sale by Graymatters Consulting on <date>04/30/2026</date>

Proceeds on 04/30/2026 (Graymatters) $580,909.44 Dollar proceeds for the 19,200-share sale on <date>04/30/2026</date>

Sale on 06/25/2026 (each) 2,300 shares 10b5-1 sales by both named holders on <date>06/25/2026</date>

Proceeds on 06/25/2026 (Lesage) $80,774.46 Dollar proceeds for the 2,300-share sale on <date>06/25/2026</date>

Key Terms

10b5-1, Rule 144, Founders Shares

3 terms

10b5-1 regulatory

"10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Rule 144 regulatory

"144: Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founders Shares market

"Common | 12/31/2016 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

What sales does the PHVS Form 144 report show?

The Form 144 lists multiple 10b5-1 sales by two holders. It shows trades on 04/30/2026 and 06/25/2026 with specific share counts and dollar proceeds for each transaction as provided in the excerpt.

Who are the named sellers in the PHVS filing?

The filing names Anne Simonne J. Lesage and Graymatters Consulting as sellers. Each is shown with several 10b5-1 sales on specified dates and associated share counts and proceeds in the excerpt.

How many shares were sold on 04/30/2026 in the filing?

On 04/30/2026 the excerpt lists sales of 21,700 shares by Anne Lesage and 19,200 shares by Graymatters Consulting, with the dollar proceeds shown alongside each trade in the filing excerpt.

Were the sales reported as 10b5-1 plan executions?

Yes. Each trade in the excerpt is labeled as a 10b5-1 Sale. The filing presents them as planned sales under that mechanism with dates, share quantities, and proceeds for each recorded transaction.

Does the excerpt state total proceeds received by the issuer?

The excerpt lists dollar proceeds per trade for the selling holders; it does not state any proceeds received by the issuer. The recorded amounts in the excerpt reflect proceeds tied to each selling-holder trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973705
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pharvaris N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	310712036410
Name of Person for Whose Account the Securities are To Be Sold	GrayMatters Consulting B.V.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6997	237967.97	65407822	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2016	Founders Shares	Issuer			6997	12/31/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80774.46
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80785.59
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	21700	656550.86
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	19200	580909.44
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111280.46
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111229.40
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7500	225361.90
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7000	210357.70

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anne Simonne J. Lesage
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)